DPYSL3 and prostate carcinoma: In prostate cancer, the expression of both DPYSL3 mRNA and protein was inversely associated with lymph node metastasis and VEGF expression, and forced DPYSL3 expression in cell lines decreased metastasis in a mouse metastatic model [14].